("Sarcoma"[Mesh]) AND "Uterine Neoplasms"[Mesh] - Search Results

Year	Number of Results
1952	1
1960	1
1962	1
1963	3
1965	1
1966	1
1967	5
1968	7
1969	1
1970	8
1971	5
1972	1
1973	2
1974	2
1975	1
1977	1
1979	1
1980	2
1981	1
1982	1
1983	4
1984	3
1985	2
1986	6
1987	1
1988	3
1989	2
1990	2
1991	5
1992	2
1993	1
1994	4
1995	4
1996	13
1997	10
1998	7
1999	14
2000	11
2001	11
2002	20
2003	15
2004	25
2005	29
2006	26
2007	32
2008	39
2009	50
2010	45
2011	51
2012	71
2013	52
2014	83
2015	92
2016	77
2017	101
2018	86
2019	88
2020	73
2021	90
2022	107
2023	102
2024	91
2025	77
2026	16

1

Data science meets FTIR Imaging: a promising probe to improve the diagnosis of human uterine muscle lesions.

Santoni C, Orilisi G, Greco S, Notarstefano V, Delli Carpini G, Gonzàlez AD, Giantomassi F, Filosa A, Goteri G, Ciavattini A, Zannoni GF, Orsini G, Giorgini E, Ciarmela P. Santoni C, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2026 May 15;353:127572. doi: 10.1016/j.saa.2026.127572. Epub 2026 Feb 11. Spectrochim Acta A Mol Biomol Spectrosc. 2026. PMID: 41707626 Free article.

2

Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot Multicenter Italian Trials in Ovarian Cancer (MITO) study.

Ciccarone F, Rizzi A, Biscione A, Baldassari G, Tran EH, Pasciuto T, Moro F, Zinicola G, Buonomo F, Colombin M, Ghezzi F, Casarin J, Mancari R, Borella F, Kardhashi A, Roccio M, Savelli L, Cioffi R, Fanfani F, Ferrandina G, Scambia G, Valentin L, Lorusso D, Testa AC. Ciccarone F, et al. Ultrasound Obstet Gynecol. 2026 Apr;67(4):530-541. doi: 10.1002/uog.70187. Epub 2026 Mar 6. Ultrasound Obstet Gynecol. 2026. PMID: 41791853 Free PMC article.

3

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

Dundr P, Radová E, Hojný J, Kudrnová N, Kendall Bártů M, Němejcová K, Kalousová M, Frühauf F, Cibula D, Matěj R, McCluggage WG, Stružinská I. Dundr P, et al. Virchows Arch. 2026 Mar;488(3):661-669. doi: 10.1007/s00428-026-04420-6. Epub 2026 Jan 28. Virchows Arch. 2026. PMID: 41606383 Free PMC article.

4

Development of a blood test for uterine sarcoma-Diagnosis and monitoring (DOORS-D and DOORS-M) studies.

Casey A, Allsopp R, Shaw J, Cowley C, Stannard E, Griffin Y, Das I, Wadsley M, Darko N, Moss EL. Casey A, et al. PLoS One. 2026 Feb 17;21(2):e0339336. doi: 10.1371/journal.pone.0339336. eCollection 2026. PLoS One. 2026. PMID: 41701790 Free PMC article.

5

Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma.

Lu W, Jiang S, Sun Q, Huang Y, Yang Y, Wang X, Zhang L, Guo Y, Chen R. Lu W, et al. Int J Med Sci. 2026 Feb 4;23(3):927-949. doi: 10.7150/ijms.126491. eCollection 2026. Int J Med Sci. 2026. PMID: 41799759 Free PMC article.

6

Huge Exogenous Pelvic Endometrial Stromal Sarcoma Penetrating the Cervix:Report of One Case.

Lu ZR, Wang T. Lu ZR, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2026 Feb;48(1):205-210. doi: 10.3881/j.issn.1000-503X.16526. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2026. PMID: 41885161 Free article.

7

Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification.

González-Martínez S, Palacios J, Carretero-Barrio I, Fernández-Lanza V, Cortés-Salgado A, Román J, Matias-Guiu X, Gatius S, Cortés J, Pérez-Mies B. González-Martínez S, et al. J Pathol. 2026 Feb;268(2):227-242. doi: 10.1002/path.70003. J Pathol. 2026. PMID: 41537454 Free PMC article.

8

An interpretable model based on weakly supervised learning for uterine smooth muscle tumor diagnosis: A multi-center study.

Wang X, Shen X, Yang M, Yang L, He Y, Ren Y, Wang S, Wu D, Guo Y, Niu Y, Peng K, Wang Z, Wu J, Li J, Wang W, Wang F, Cui L, Wang W, Liu C, Zhong D. Wang X, et al. Pathol Res Pract. 2026 Feb;278:156337. doi: 10.1016/j.prp.2025.156337. Epub 2025 Dec 17. Pathol Res Pract. 2026. PMID: 41421323 Free article.

9

Risk factors for recurrent cases of early-stage uterine sarcoma after complete surgical resection.

Nagao Y, Yokoi A, Yoshida K, Yoshihara M, Tamauchi S, Yoshikawa N, Niimi K, Kajiyama H. Nagao Y, et al. BMC Cancer. 2026 Jan 26;26(1):288. doi: 10.1186/s12885-026-15618-x. BMC Cancer. 2026. PMID: 41588380 Free PMC article.

10

Uterine carcinosarcoma due to foreign body (migrated intrauterine device): an extremely rare etiology of gynecological neoplasm.

Vallejo-Soto JC, Farías JLT, Rojas-Oviedo JL, Borda LMP, Castañeda CAS. Vallejo-Soto JC, et al. BMC Surg. 2026 Jan 20;26(1):135. doi: 10.1186/s12893-025-03483-7. BMC Surg. 2026. PMID: 41559694 Free PMC article.

11

Fertility-sparing treatment for low-grade endometrial stromal sarcoma.

Xu B, You Y, Wu H, Li L. Xu B, et al. Eur J Med Res. 2026 Jan 5;31(1):193. doi: 10.1186/s40001-025-03830-7. Eur J Med Res. 2026. PMID: 41491971 Free PMC article.

12

Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.

Qian XF, Wang XW, Yi HQ, Li LF. Qian XF, et al. Am J Case Rep. 2026 Jan 4;27:e949701. doi: 10.12659/AJCR.949701. Am J Case Rep. 2026. PMID: 41485090 Free PMC article.

13

Immune landscape and potential role of immune checkpoint inhibitors on uterine leiomyosarcoma: a review.

Borella F, Gallio N, Ferraioli D, Ray-Coquard I, Cosma S. Borella F, et al. Int J Gynecol Cancer. 2026 Jan;36(1):102815. doi: 10.1016/j.ijgc.2025.102815. Epub 2025 Nov 21. Int J Gynecol Cancer. 2026. PMID: 41365077 Free article. Review.

14

Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma.

Furuya RL, Grither W, Evans MG, Wu S, Hechtman JF, Krause HB, Elliott A, Mathews C, Oliver MT, Miller K, Wei S, Ali-Fehmi R, Bryant DA, Oberley MJ, Powell MA, Thaker PH. Furuya RL, et al. Gynecol Oncol. 2026 Jan;204:17-22. doi: 10.1016/j.ygyno.2025.10.034. Epub 2025 Nov 13. Gynecol Oncol. 2026. PMID: 41232209 Free article.

15

Secondary Lower-Body Sarcomas in Cervical Cancer Survivors Following Surgery, Radiotherapy, or Both: A Population-Based Study.

Ikawa T, Nakata K, Morishima T, Yoshida KI, Kuwabara Y, Kato MS, Iwaki Y, Kanayama N, Morimoto M, Konishi K, Miyashiro I. Ikawa T, et al. Cancer Sci. 2026 Jan;117(1):216-225. doi: 10.1111/cas.70229. Epub 2025 Nov 9. Cancer Sci. 2026. PMID: 41208291 Free PMC article.

16

Molecular Pathogenesis of Uterine Sarcomas: Mechanisms and Implications for Treatment.

Chiang S. Chiang S. Annu Rev Pathol. 2026 Jan;21(1):239-267. doi: 10.1146/annurev-pathmechdis-111523-023434. Epub 2025 Oct 14. Annu Rev Pathol. 2026. PMID: 41086256 Free article. Review.

17

Uterine leiomyosarcoma diagnostic challenges in a resource-limited setting: a case report and review of the literature.

Addis NA, Yigzaw KT, Asfaw BA, Adisu GD, Mekonnen MF, Worku MA, Shibesh MH, Yigezaw GS. Addis NA, et al. J Med Case Rep. 2025 Dec 24;19(1):642. doi: 10.1186/s13256-025-05697-y. J Med Case Rep. 2025. PMID: 41444925 Free PMC article. Review.

18

Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma.

Toyohara Y, Sone K, Kumegawa K, Yamamoto Y, Hachijo R, Kukita A, Taguchi A, Ikemura M, Miyamoto Y, Tanikawa M, Iriyama T, Mori M, Hamamoto R, Ushiku T, Oda K, Hirota Y, Maruyama R, Osuga Y. Toyohara Y, et al. BMC Cancer. 2025 Dec 16;25(1):1873. doi: 10.1186/s12885-025-15267-6. BMC Cancer. 2025. PMID: 41402789 Free PMC article.

19

Undifferentiated Uterine Sarcoma With SMARCA4 Gene Deletion: Report of Two Cases and Literature Review.

DU SX, Yang HY. DU SX, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025 Dec;47(6):1051-1056. doi: 10.3881/j.issn.1000-503X.16380. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025. PMID: 41503660 Free article. Review.

20

Uterine sarcomas: Computed tomography and magnetic resonance imaging findings.

Qu Q, Ma Z, Liu G, Zhang X, Xu C, Wu X. Qu Q, et al. J Cancer Res Ther. 2025 Dec 1;21(6):1207-1212. doi: 10.4103/jcrt.jcrt_473_25. Epub 2025 Dec 31. J Cancer Res Ther. 2025. PMID: 41474243 Free article.

21

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

Washington C, Dwivedi SKD, Gunderson-Jackson C, Walker J, Mannel RS, Holman LL, Richardson DL, Neelakantan D, Cohoon A, Ding K, Gatalica Z, Moxley KM, Landrum LM, Rowland MR, Bhattacharya R, Moore KN. Washington C, et al. Gynecol Oncol. 2025 Dec;203:158-164. doi: 10.1016/j.ygyno.2025.10.021. Epub 2025 Nov 5. Gynecol Oncol. 2025. PMID: 41197229 Free PMC article. Clinical Trial.

22

Timing and survival benefits of cytoreduction in patients with recurrent leiomyosarcoma.

Tunç M, Akıllı H, Kuşçu E, Ayhan A. Tunç M, et al. Arch Gynecol Obstet. 2025 Dec;312(6):1985-1990. doi: 10.1007/s00404-025-08140-1. Epub 2025 Oct 17. Arch Gynecol Obstet. 2025. PMID: 41107513 Free PMC article.

23

Real-world insights into the prevalence and prognostic significance of trophoblast cell-surface antigen 2 and folate receptor alpha in uterine carcinosarcoma.

de Albuquerque LZ, da Silva JL, Rodrigues FR, Fernandes PV, Small IÁ, Leite LF, Guitmann G, de Melo AC. de Albuquerque LZ, et al. BMC Cancer. 2025 Nov 25;25(1):1914. doi: 10.1186/s12885-025-15298-z. BMC Cancer. 2025. PMID: 41286743 Free PMC article.

24

Identification of radiotherapy-sensitive genes for predicting prognosis, immune microenvironment, and drug sensitivity in uterine carcinosarcoma patients.

Zhou Y, Cui R, Lei D, Gao S. Zhou Y, et al. Medicine (Baltimore). 2025 Nov 21;104(47):e46186. doi: 10.1097/MD.0000000000046186. Medicine (Baltimore). 2025. PMID: 41305766 Free PMC article.

25

Diagnostic and prognostic values of circulating growth differentiation factor-15 and osteopontin in uterine sarcoma.

Tsuyoshi H, Mizutani T, Uno M, Kato T, Orisaka M, Yoshida Y. Tsuyoshi H, et al. Sci Rep. 2025 Nov 19;15(1):40839. doi: 10.1038/s41598-025-24481-y. Sci Rep. 2025. PMID: 41258259 Free PMC article.

26

Müllerian adenosarcoma mimicking cervical carcinoma in a 79-year-old woman: diagnostic challenges and laparoscopic treatment: a case report.

Zhang F, Hu J, Bian J, Lan Y. Zhang F, et al. Pan Afr Med J. 2025 Nov 13;52:110. doi: 10.11604/pamj.2025.52.110.49172. eCollection 2025. Pan Afr Med J. 2025. PMID: 41624694 Free PMC article.

27

Specific transcriptional signature dataset of extracellular signal-regulated kinase 5 in leiomyosarcoma derived cell lines.

Jiménez-Suárez J, Garnés-García C, Fernández-Aroca P, Aparicio-Canada J, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R, Cimas FJ. Jiménez-Suárez J, et al. BMC Res Notes. 2025 Nov 13;18(1):477. doi: 10.1186/s13104-025-07551-2. BMC Res Notes. 2025. PMID: 41233882 Free PMC article.

28

MicroRNAs in Uterine Leiomyosarcoma: From Molecular Mechanisms to Clinical Applications.

Kourti A, Kalogiannidis I, Makedou K, Georgiou E. Kourti A, et al. Int J Mol Sci. 2025 Nov 12;26(22):10952. doi: 10.3390/ijms262210952. Int J Mol Sci. 2025. PMID: 41303434 Free PMC article. Review.

29

High-grade uterine endometrial stromal sarcoma harboring GLI1 and MDM2/CDK4 co-amplifications.

Zhang L, Luan L, Zhang L, Huang Y, Gu W, Yu S, Shen L, Huang J, Shao Y, Su J, Hou Y, Xu C. Zhang L, et al. Diagn Pathol. 2025 Nov 6;20(1):125. doi: 10.1186/s13000-025-01716-0. Diagn Pathol. 2025. PMID: 41199293 Free PMC article.

30

Molecular subtypes and quantitative analysis of PD-L1 and tumor-associated immune cells in uterine carcinosarcoma.

Sun L, Gao X, Zhao Z, Zhu Y. Sun L, et al. J Gynecol Oncol. 2025 Nov;36(6):e114. doi: 10.3802/jgo.2025.36.e114. Epub 2025 May 7. J Gynecol Oncol. 2025. PMID: 40405429 Free PMC article.

31

Metastatic endometrial stromal sarcoma with sex cord and neuroendocrine differentiation harboring a complex gene fusion.

Sibira R, Cooke K, Shah A, Li X, Sen S, Varghese L, Klein M. Sibira R, et al. Diagn Pathol. 2025 Oct 16;20(1):115. doi: 10.1186/s13000-025-01720-4. Diagn Pathol. 2025. PMID: 41102766 Free PMC article.

32

Carcinosarcoma of the cervix: Clinicopathological features of 17 tumors diagnosed at a Tertiary Cancer Referral Centre, India.

Majumder A, Rekhi B, Mittal N, Menon S, Deodhar KK, Ghosh J, Maheshwari A. Majumder A, et al. Indian J Pathol Microbiol. 2025 Oct 1;68(4):744-753. doi: 10.4103/ijpm.ijpm_73_25. Epub 2025 Aug 14. Indian J Pathol Microbiol. 2025. PMID: 40824725 Free article.

33

Endometrial carcinosarcoma without myoinvasion.

Cucinella G, Zammarrelli WA 3rd, Nasioudis D, Gabrilovich S, Capasso I, Berretta R, Scollo P, Raspagliesi F, Baiocchi G, Barresi G, Pecorino B, Bogani G, Kurnit KC, De Brot L, Lembo A, Maryam S, Fought AJ, McGree ME, Chiantera V, Bosquet JG, Fanfani F, Scambia G, Abu-Rustum NR, Mariani A, Giuntoli R 2nd, Glaser G, Leitao MM Jr. Cucinella G, et al. Int J Gynecol Cancer. 2025 Oct;35(10):101971. doi: 10.1016/j.ijgc.2025.101971. Epub 2025 Jun 16. Int J Gynecol Cancer. 2025. PMID: 40731228 Free PMC article.

34

High visceral-to-subcutaneous fat area ratio is an unfavorable prognostic indicator in patients with uterine sarcoma.

Kurokawa M, Gonoi W, Hanaoka S, Kurokawa R, Uehara S, Kato M, Suzuki M, Toyohara Y, Takaki Y, Kusakabe M, Kino N, Tsukazaki T, Unno T, Sone K, Abe O. Kurokawa M, et al. Jpn J Radiol. 2025 Oct;43(10):1670-1677. doi: 10.1007/s11604-025-01812-7. Epub 2025 Jun 12. Jpn J Radiol. 2025. PMID: 40500581 Free PMC article.

35

High-grade endometrial stromal sarcoma presenting with multiple brain metastases: a case report.

Kono H, Toyoshima M, Ikki A, Shimada H, Suzuki S. Kono H, et al. J Med Case Rep. 2025 Sep 25;19(1):442. doi: 10.1186/s13256-025-05448-z. J Med Case Rep. 2025. PMID: 40999470 Free PMC article.

36

Two cases of uterine leiomyosarcoma misdiagnosed as intravenous leiomyomatosis before surgery: A case report.

Yang Y, Ma G, Lai Z, Ma X, Cao D, Li K, Shao J, Liu B. Yang Y, et al. Medicine (Baltimore). 2025 Sep 19;104(38):e43961. doi: 10.1097/MD.0000000000043961. Medicine (Baltimore). 2025. PMID: 40988291 Free PMC article.

37

Immunotherapy for high-grade endometrial stromal sarcoma: a narrative review bridging molecular insights to clinical translation.

Zhao L, Su Y, Li X, Wang F, He L, Fan L, Zhang L. Zhao L, et al. Front Immunol. 2025 Sep 4;16:1645371. doi: 10.3389/fimmu.2025.1645371. eCollection 2025. Front Immunol. 2025. PMID: 40977714 Free PMC article. Review.

38

Real-world clinical outcomes of patients with high-risk endometrial cancer or endometrial carcinosarcoma in England: A retrospective cohort study.

Prabhu VS, Landfeldt E, Ralphs E, Teoh C, Ridsdale-Smith J, Macey K, Trankov N, Lambova A, Lichfield J, Eminowicz G. Prabhu VS, et al. J Obstet Gynaecol Res. 2025 Sep;51(9):e70042. doi: 10.1111/jog.70042. J Obstet Gynaecol Res. 2025. PMID: 40968788 Free PMC article.

39

Long-Term Complete Remission of Metastatic Endometrial Carcinosarcoma With Radical Surgical Resection and Postoperative Chemotherapy Utilizing Paclitaxel and Carboplatin.

Novin K, Shahrokh S, Shahin M, Taghizadeh-Hesary F. Novin K, et al. Cancer Rep (Hoboken). 2025 Sep;8(9):e70346. doi: 10.1002/cnr2.70346. Cancer Rep (Hoboken). 2025. PMID: 40922694 Free PMC article.

40

Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage.

Lee KJ, Chokshi S, Joshi T, Cummings M, Ramirez-Alcantara V, Turbat-Herrera EA, Rocconi RP, Scalici J, Pierce J, Jones N. Lee KJ, et al. Gynecol Oncol. 2025 Sep;200:80-87. doi: 10.1016/j.ygyno.2025.07.016. Epub 2025 Jul 23. Gynecol Oncol. 2025. PMID: 40706253 Free article.

41

Single-cell profiling delineates the tumor microenvironment and immunological networks in patient-derived uterine leiomyosarcoma.

Guo Y, Shen D, Xiao Y, Wu C, Chen M, Yang L, Li H, Tong X, Chen R, Li F. Guo Y, et al. Front Immunol. 2025 Aug 29;16:1653096. doi: 10.3389/fimmu.2025.1653096. eCollection 2025. Front Immunol. 2025. PMID: 40948800 Free PMC article.

42

Uterine intermural adenosarcoma arising from adenomyoma: A case report and review of literature.

Qiu J, Yuan L. Qiu J, et al. Medicine (Baltimore). 2025 Aug 29;104(35):e43829. doi: 10.1097/MD.0000000000043829. Medicine (Baltimore). 2025. PMID: 40898570 Free PMC article. Review.

43

Sarcomatoid transformation of uterine myoma identified through physical examination: a case report.

Zhou X, Wu C, Shi M. Zhou X, et al. J Med Case Rep. 2025 Aug 20;19(1):420. doi: 10.1186/s13256-025-05447-0. J Med Case Rep. 2025. PMID: 40836343 Free PMC article.

44

SMARCA4-deficient undifferentiated uterine sarcoma: A case report and literature review.

Wang Y, Sun Y, Jiang Y, Chen X, Dai H. Wang Y, et al. Medicine (Baltimore). 2025 Aug 15;104(33):e43828. doi: 10.1097/MD.0000000000043828. Medicine (Baltimore). 2025. PMID: 40826772 Free PMC article. Review.

45

A Rare Case of Uterine Embryonal Rhabdomyosarcoma.

Moustafa S, Uzianbaeva L, Paczos T, Smith H, Wang P. Moustafa S, et al. CRSLS. 2025 Aug 7;12(3):e2025.00033. doi: 10.4293/CRSLS.2025.00033. eCollection 2025 Jul-Sep. CRSLS. 2025. PMID: 40787277 Free PMC article.

46

Alveolar rhabdomyosarcoma of cervix: A case report.

Zhang X, Xu J. Zhang X, et al. Medicine (Baltimore). 2025 Aug 1;104(31):e43675. doi: 10.1097/MD.0000000000043675. Medicine (Baltimore). 2025. PMID: 40760595 Free PMC article.

47

Survival guided adaptive clustering enhances mortality risk stratification and radiotherapy guidance in early stage uterine sarcoma.

Zhou X, Yuan S, Li T, Zhang T, Wang W, Zhu X. Zhou X, et al. Sci Rep. 2025 Jul 25;15(1):27055. doi: 10.1038/s41598-025-13139-4. Sci Rep. 2025. PMID: 40715603 Free PMC article.

48

Lymphoepithelioma-like carcinoma with carcinosarcoma of the endometrium: a case report and literature review.

Xu J, Huang B, Zhu Y, Shi J, Zhou Q. Xu J, et al. Front Immunol. 2025 Jul 21;16:1636575. doi: 10.3389/fimmu.2025.1636575. eCollection 2025. Front Immunol. 2025. PMID: 40761799 Free PMC article. Review.

49

Adenosarcoma of uterus characterized by differentiation of rhabdomyosarcoma and chondrosarcoma: A case report and review of literature.

Yang G, Lu Y, An Y, He X, Ma D, Jiao L, Li Y. Yang G, et al. Sci Prog. 2025 Jul-Sep;108(3):368504251362743. doi: 10.1177/00368504251362743. Epub 2025 Sep 4. Sci Prog. 2025. PMID: 40906397 Free PMC article. Review.

50

Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study.

Yamanishi Y, Kotani Y, Kido A, Otani T, Himoto Y, Kurata Y, Murakami K, Takaya H, Sumitomo M, Emoto I, Matsubara M, Horikawa N, Akagi K, Ishida K, Takaori A, Sakurai A, Abiko K, Yamanoi K, Mandai M, Matsumura N. Yamanishi Y, et al. J Gynecol Oncol. 2025 Jul;36(4):e58. doi: 10.3802/jgo.2025.36.e58. Epub 2025 Apr 4. J Gynecol Oncol. 2025. PMID: 40223553 Free PMC article.

51

Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis.

Berthet J, Kime A, Borghese B, De Percin S, Gaudet-Chardonnet A, Alexandre J, Beinse G. Berthet J, et al. J Gynecol Oncol. 2025 Jul;36(4):e64. doi: 10.3802/jgo.2025.36.e64. Epub 2025 Mar 23. J Gynecol Oncol. 2025. PMID: 40223552 Free PMC article.

52

A Case of Uterine Adenosarcoma and Colonic Endometriosis Masquerading as Inflammatory Bowel Disease.

Lin CJ, Chiang YC, Su TH, Shih IL, Kuo KT, Wei SC, Tai YJ. Lin CJ, et al. Dig Dis Sci. 2025 Jul;70(7):2229-2232. doi: 10.1007/s10620-025-08988-y. Epub 2025 Mar 21. Dig Dis Sci. 2025. PMID: 40119242 Free PMC article.

53

Poor accuracy of endometrial sampling in patients with uterine carcinosarcomas: a nationwide analysis.

Pham ENB, van den Berg CB, van Es R, van Doorn HC, Groenendijk FH, van Beekhuizen HJ. Pham ENB, et al. J Gynecol Oncol. 2025 Jul;36(4):e52. doi: 10.3802/jgo.2025.36.e52. Epub 2025 Jan 2. J Gynecol Oncol. 2025. PMID: 39853259 Free PMC article.

54

A Case of NTRK Fusion Corpus Sarcoma With Pseudobiphasic Growth Pattern and Literature Review.

Zhang XY, Jiang HW, Wen XB, Yu Q, Li Y, Wang H, Han J, Yang SC. Zhang XY, et al. Int J Gynecol Pathol. 2025 Jul 1;44(4):374-383. doi: 10.1097/PGP.0000000000001078. Epub 2024 Dec 26. Int J Gynecol Pathol. 2025. PMID: 39729556 Free PMC article. Review.

55

Carcinosarcoma of the Endometrium-Pathology, Molecular Landscape and Novel Therapeutic Approaches.

Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Wafa M, Ivanova Y, Slavchev S, Tsoneva E, Yordanov A. Kostov S, et al. Medicina (Kaunas). 2025 Jun 26;61(7):1156. doi: 10.3390/medicina61071156. Medicina (Kaunas). 2025. PMID: 40731786 Free PMC article. Review.

56

Clinicopathological pitfalls associated with benign uterine mesenchymal tumors: A single-center experience.

Iwabuchi S, Sato Y, Okamoto M, Yano M, Kobayashi E. Iwabuchi S, et al. Medicine (Baltimore). 2025 Jun 13;104(24):e42852. doi: 10.1097/MD.0000000000042852. Medicine (Baltimore). 2025. PMID: 40527829 Free PMC article.

57

Emergency Radiation Therapy for Hemorrhage in Botryoides Sarcoma: A Pediatric Case Report.

Waluyo ST, Yuseran H, Armanza F, Manalu FFEC. Waluyo ST, et al. Am J Case Rep. 2025 Jun 5;26:e946434. doi: 10.12659/AJCR.946434. Am J Case Rep. 2025. PMID: 40468567 Free PMC article.

58

Heterochronic pelvic high-grade myxoinflammatory fibroblastic sarcoma and uterine endometroid carcinoma harboring common gene mutations: a rare case report with genomic analysis.

Higashi Y, Mizuno M, Kitazono I, Akahane T, Tasaki T, Noguchi H, Hisaoka M, Kobayashi H, Tanimoto A. Higashi Y, et al. Diagn Pathol. 2025 Jun 3;20(1):71. doi: 10.1186/s13000-025-01669-4. Diagn Pathol. 2025. PMID: 40462124 Free PMC article.

59

Establishment and comparison of three sublines from a human uterine carcinosarcoma cell line, ESCA.

Long Y, Pei X, Liu H, Ouyang X, Jiang W, Yang H. Long Y, et al. Hum Cell. 2025 Jun 2;38(4):115. doi: 10.1007/s13577-025-01225-8. Hum Cell. 2025. PMID: 40455147 Free PMC article.

60

Dual Targeting EZH2 and Histone Deacetylases in Human Uterine Sarcoma Cells Under Both 2D and 3D Culture Conditions.

Omran MM, Vafaei S, Alkhrait S, Yang Q, Al-Hendy A. Omran MM, et al. J Cell Mol Med. 2025 Jun;29(11):e70626. doi: 10.1111/jcmm.70626. J Cell Mol Med. 2025. PMID: 40464712 Free PMC article.

61

MG132 induces cell type‑specific anticancer effects in uterine leiomyosarcoma cell lines.

Joung H, Seo S, Liu H. Joung H, et al. Mol Med Rep. 2025 Jun;31(6):159. doi: 10.3892/mmr.2025.13524. Epub 2025 Apr 11. Mol Med Rep. 2025. PMID: 40211694 Free PMC article.

62

Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series.

Flídrová M, Dundr P, Vránková R, Němejcová K, Cibula D, Poncová R, Michalová K, Bouda J, Laco J, Ndukwe M, Ryś J, Książek M, Berjon A, Zapardiel I, Franin I, Njavro A, Hausnerová J, Bretová P, Židlík V, Klát J, Krasznai ZT, Poka R, Volodko N, Yezhova I, Pilka R, Marek R, Kolnikova G, Krkoška M, Halaška M, Drozenová J, Dolinská D, Kalist V, Bobiński M, Ostrowska-Leśko M, Bizoń M, Sawicki W, Stukan M, Grabowska K, Jędryka M, Poprawski T, Stolnicu S, Căpîlna ME, Špůrková Z, Zikán M, Ciccarone F, Scambia G, Sharashenidze A, Gudadze M, Piatnytska T, Varchak I, Kendall Bártů M. Flídrová M, et al. Virchows Arch. 2025 Jun;486(6):1289-1304. doi: 10.1007/s00428-025-04026-4. Epub 2025 Jan 21. Virchows Arch. 2025. PMID: 39836188 Free PMC article.

63

Molecular Landscape of Endometrial Stromal Tumors.

Brunetti M, Vitelli V, Naas AM, Zahl Eriksson AG, Haugland HK, Krakstad C, Micci F. Brunetti M, et al. JCO Precis Oncol. 2025 May;9:e2400779. doi: 10.1200/PO-24-00779. Epub 2025 May 22. JCO Precis Oncol. 2025. PMID: 40403211 Free PMC article.

64

Adjuvant hormone therapy and overall survival among low-grade and apparent early-stage endometrial stromal sarcoma patients.

Bixel KL, Meade CE, Brown M, Felix AS. Bixel KL, et al. J Gynecol Oncol. 2025 May;36(3):e50. doi: 10.3802/jgo.2025.36.e50. Epub 2024 Dec 16. J Gynecol Oncol. 2025. PMID: 39727414 Free PMC article.

65

Peritoneal cytology predicting distant metastasis in uterine carcinosarcoma: machine learning model development and validation.

Lin Q, Guan Q, Chen D, Li L, Lin Y. Lin Q, et al. World J Surg Oncol. 2025 Apr 26;23(1):167. doi: 10.1186/s12957-025-03771-9. World J Surg Oncol. 2025. PMID: 40287676 Free PMC article.

66

A rare case of Alveolar Soft-Part Sarcoma in the Uterine cervix.

Du M, Li Y, Fan X, Gao H, Shi J, Cheng S, Meng T. Du M, et al. Diagn Pathol. 2025 Apr 2;20(1):33. doi: 10.1186/s13000-025-01620-7. Diagn Pathol. 2025. PMID: 40176092 Free PMC article.

67

Advancements in uterine sarcoma management: A review.

Lebar V, Čelebić A, Calleja-Agius J, Jakimovska Stefanovska M, Drusany Staric K. Lebar V, et al. Eur J Surg Oncol. 2025 Apr;51(4):109646. doi: 10.1016/j.ejso.2025.109646. Epub 2025 Jan 28. Eur J Surg Oncol. 2025. PMID: 40312227 Free article. Review.

68

Retrospective Analysis of BRCA-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase Inhibitors.

Rao M, Merrill M, Troxel M, Chiang S, Momeni-Boroujeni A, Hensley ML, Schram AM. Rao M, et al. JCO Precis Oncol. 2025 Mar;9:e2400765. doi: 10.1200/PO-24-00765. Epub 2025 Mar 21. JCO Precis Oncol. 2025. PMID: 40117531 Free PMC article.

69

Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.

Toboni M, Kurnit K, Erickson B, Powell M, Secord AA, Fader AN. Toboni M, et al. Int J Gynecol Cancer. 2025 Mar;35(3):101672. doi: 10.1016/j.ijgc.2025.101672. Epub 2025 Jan 30. Int J Gynecol Cancer. 2025. PMID: 40056788 Free PMC article. Review.

70

Identification of increased dedifferentiation along the Prom1+ cancer cells in Müllerian adenosarcoma with sarcomatous overgrowth.

Ye X, Zheng J, Hu D, Liu L, Chen F, Cai X, Xu Y, Li L, Lin J, Liu Q, Sun Y. Ye X, et al. Br J Cancer. 2025 Mar;132(5):438-449. doi: 10.1038/s41416-025-02943-4. Epub 2025 Feb 7. Br J Cancer. 2025. PMID: 39920368 Free PMC article.

71

Deep multi-omics integration approach reveals new molecular features of uterine leiomyosarcoma.

Falcao RM, de Souza JES, Gonzalez-Molina J, Mathieson W, Carlson JW, Petta TB. Falcao RM, et al. Biochim Biophys Acta Mol Basis Dis. 2025 Mar;1871(3):167632. doi: 10.1016/j.bbadis.2024.167632. Epub 2024 Dec 19. Biochim Biophys Acta Mol Basis Dis. 2025. PMID: 39708976 Free article.

72

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases.

Dundr P, Dvořák J, Krausová M, Hojný J, Hájková N, Stružinská I, Němejcová K, Ondič O, Michal M, Michalová K, Berjón A, Jedryka M, Książek M, Poprawski T, Ryś J, Volodko N, Zapardiel I, Zima T, Cibula D, Poncová R, Matěj R, Kendall Bártů M. Dundr P, et al. Virchows Arch. 2025 Mar;486(3):551-562. doi: 10.1007/s00428-024-03994-3. Epub 2024 Dec 4. Virchows Arch. 2025. PMID: 39627614 Free PMC article.

73

POLE-Mutated Uterine Carcinosarcomas: A Clinicopathologic and Molecular Study of 11 Cases.

Hammer PM, Momeni-Boroujeni A, Kolin DL, Kingsley L, Folkins A, Geisick RLP, Ho C, Suarez CJ, Howitt BE. Hammer PM, et al. Mod Pathol. 2025 Mar;38(3):100676. doi: 10.1016/j.modpat.2024.100676. Epub 2024 Nov 29. Mod Pathol. 2025. PMID: 39615841 Free article.

74

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates.

Serbes ED, Horeweg N, Parra-Herran C, van Rijnsoever R, Jobsen JJ, Jurgenliemk-Schulz I, Kuijsters N, Nout RA, Haverkort MAD, Powell ME, Khaw P, Plante M, Genestie C, Nijman HW, Creutzberg CL, Bosse T, Kramer CJH. Serbes ED, et al. Mod Pathol. 2025 Mar;38(3):100660. doi: 10.1016/j.modpat.2024.100660. Epub 2024 Nov 20. Mod Pathol. 2025. PMID: 39577664 Free article.

75

A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma.

Lu TF, Sun L, Shih YH, Chen YF, Fan CT, Wang SJ, Hsu ST, Liu CK, Hwang SF, Lu CH. Lu TF, et al. BMC Med. 2025 Feb 21;23(1):99. doi: 10.1186/s12916-025-03916-3. BMC Med. 2025. PMID: 39984939 Free PMC article.

76

Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches.

Costa A, Astolfi A, Gozzellino L, Nannini M, Pasquinelli G, Pantaleo MA. Costa A, et al. Biomolecules. 2025 Feb 11;15(2):265. doi: 10.3390/biom15020265. Biomolecules. 2025. PMID: 40001568 Free PMC article. Review.

77

Uterine leiomyosarcoma as a rare cause of fatal retroperitoneal haemorrhage due to compression and rupture of the renal vein.

Lodetti G, Tambuzzi S, Andreola S, Gentile G, Zoja R. Lodetti G, et al. J Forensic Leg Med. 2025 Feb;110:102804. doi: 10.1016/j.jflm.2025.102804. Epub 2025 Jan 27. J Forensic Leg Med. 2025. PMID: 39893750 Free article.

78

Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei.

Felicelli C, Lu X, Coty-Fattal Z, Feng Y, Yin P, Schipma MJ, Kim JJ, Jennings LJ, Bulun SE, Wei JJ. Felicelli C, et al. J Pathol. 2025 Feb;265(2):211-225. doi: 10.1002/path.6379. Epub 2024 Dec 18. J Pathol. 2025. PMID: 39691991 Free PMC article.

79

Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer.

Haanen TJ 3rd, Boock S, Callahan CG, Peris I, Zawacki KP, Raines B, Nino CA, Tran B, Harold A, Hodges Onishi G, Hinderman M, Dowdican A, Huang W, Taylor DJ, Taylor SE, Jackson MW, DiFeo A, O'Connor CM, Narla G. Haanen TJ 3rd, et al. Cancer Res. 2025 Feb 1;85(3):442-461. doi: 10.1158/0008-5472.CAN-24-1263. Cancer Res. 2025. PMID: 39531506 Free PMC article.

80

Validation of biomarkers and clinical scores for the detection of uterine leiomyosarcoma: a case-control study with an update of pLMS.

Vollmer M, Köhler G, Radosa JC, Zygmunt M, Zimmermann J, Köller M, Seitz C, Bralo H, Radosa MP, Kaya AC, Krichbaum J, Solomayer EF, Kaderali L, Alwafai Z. Vollmer M, et al. BMC Cancer. 2025 Jan 8;25(1):33. doi: 10.1186/s12885-024-13396-y. BMC Cancer. 2025. PMID: 39773707 Free PMC article.

81

[Uterine leiomyosarcoma with metastasis to the pancreatic tail].

Pratto D, Bello M, Polanco V, Danze L, Espil G, Shigeru K, Larrañaga N. Pratto D, et al. Medicina (B Aires). 2025;85(5):1142-1145. Medicina (B Aires). 2025. PMID: 41109297 Free article. Spanish.

82

Prognostic Role of Radiotherapy in Low-Grade Endometrial Stromal Sarcoma: A SEER-Based Study.

Jian H, Guo J, Zhao W, Liu W, Xiang Y, Wang X. Jian H, et al. Cancer Control. 2025 Jan-Dec;32:10732748251356935. doi: 10.1177/10732748251356935. Epub 2025 Jun 30. Cancer Control. 2025. PMID: 40588787 Free PMC article.

83

β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma.

Cai Y, Wang Y, Yang L, Huang Y, Chen MJ, Zhang C, Jin SH, Frey B, Gaipl US, Ma H, Zhou JG. Cai Y, et al. Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251345208. doi: 10.1177/15330338251345208. Epub 2025 May 21. Technol Cancer Res Treat. 2025. PMID: 40398662 Free PMC article.

84

Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma.

Yuan D, Huang Y, Cai Y, Zhang C, Wang JJ, Zhou JG. Yuan D, et al. Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251343487. doi: 10.1177/15330338251343487. Epub 2025 May 19. Technol Cancer Res Treat. 2025. PMID: 40388709 Free PMC article.

85

Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines.

Hwang WY, Kim JH, Noh JJ, Baek MH, Choi MC, Lee YJ, Lee M, Suh DH, Kim YB, Kim DY. Hwang WY, et al. J Gynecol Oncol. 2025 Jan;36(1):e71. doi: 10.3802/jgo.2025.36.e71. J Gynecol Oncol. 2025. PMID: 39900346 Free PMC article.

86

Integrated Transcriptomic Landscape and Deep Learning Based Survival Prediction in Uterine Sarcomas.

Song Y, Li G, Zhang Z, Liu Y, Jia H, Zhang C, Wang J, Hu Y, Hao F, Liu X, Xie Y, Ma D, Li G, Tai Z, Xing X. Song Y, et al. Cancer Res Treat. 2025 Jan;57(1):250-266. doi: 10.4143/crt.2024.343. Epub 2024 Jul 10. Cancer Res Treat. 2025. PMID: 38993092 Free PMC article.

87

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma.

Mizoguchi C, Nishikawa T, Yoshida H, Yasuda M, Kato T, Hasegawa K, Yonemori K. Mizoguchi C, et al. J Gynecol Oncol. 2025 Jan;36(1):e14. doi: 10.3802/jgo.2025.36.e14. Epub 2024 Jul 2. J Gynecol Oncol. 2025. PMID: 38991945 Free PMC article.

88

The Spectrum of Fusions Occurring in Non-Smooth Muscle Mesenchymal Uterine Tumors: A Review of the Current Knowledge.

Dundr P, Matěj R, Hojný J, Hájková N, Němejcová K, Kendall Bártů M. Dundr P, et al. Arch Pathol Lab Med. 2025 Jan 1;149(1):90-102. doi: 10.5858/arpa.2023-0324-RA. Arch Pathol Lab Med. 2025. PMID: 38484759 Free article. Review.

89

TOURISM study (Treatment Outcomes in UteRIne SarcoMa): a 10-year retrospective evaluation of practice in the UK.

Mactier KE, Baxter MA, Peters AL, Fair K, Hannington L, Robertson J, Wood GE, Sarwar A, Bishr MK, Webb R, Al-Zubaidi M, Eastlake L, Lankester K, McInerney S, Creedon H, Stillie AL, Purshouse K; National Oncology Trainee Collaborative for Healthcare Research. Mactier KE, et al. BMJ Open. 2024 Dec 26;14(12):e094838. doi: 10.1136/bmjopen-2024-094838. BMJ Open. 2024. PMID: 39725428 Free PMC article.

90

Undifferentiated uterine sarcoma : experience of a single center.

Yuan H, Wang T, Li N, Yao H. Yuan H, et al. World J Surg Oncol. 2024 Dec 5;22(1):325. doi: 10.1186/s12957-024-03610-3. World J Surg Oncol. 2024. PMID: 39633460 Free PMC article.

91

Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study.

Saab R, Fellman BM, Legarreta AF, Meyer LA, Fleming ND, Ratan R, Nassif Haddad EF, Frumovitz M, Soliman PT. Saab R, et al. Gynecol Oncol. 2024 Dec;191:143-149. doi: 10.1016/j.ygyno.2024.10.008. Epub 2024 Oct 12. Gynecol Oncol. 2024. PMID: 39396406 Free PMC article.

92

Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma.

Miao Y, Dong M, Zhou Q, Thiel J, Li N, Cai Y, Yuan D, Wang H, Jin SH, Yang H, Wang J, Frey B, Gaipl US, Ma H, Zhou JG. Miao Y, et al. Front Immunol. 2024 Nov 29;15:1513076. doi: 10.3389/fimmu.2024.1513076. eCollection 2024. Front Immunol. 2024. PMID: 39676856 Free PMC article.

93

Uterine carcinosarcoma: Unraveling the role of epithelial-to-mesenchymal transition in progression and therapeutic potential.

Gopinatha Pillai MS, Shaw P, Dey Bhowmik A, Bhattacharya R, Rao G, Dhar Dwivedi SK. Gopinatha Pillai MS, et al. FASEB J. 2024 Nov 15;38(21):e70132. doi: 10.1096/fj.202401991R. FASEB J. 2024. PMID: 39475331 Free PMC article. Review.

94

Uterine mesenchymal tumours harboring the KAT6B/A::KANSL1 gene fusion represent a distinct type of uterine sarcoma based on DNA methylation profiles.

Kommoss FKF, Charbel A, Kolin DL, Howitt BE, Köbel M, Lee JC, McCluggage WG, Agaimy A, Dickson BC, von Deimling A, Lee CH. Kommoss FKF, et al. Virchows Arch. 2024 Nov;485(5):793-803. doi: 10.1007/s00428-024-03935-0. Epub 2024 Oct 11. Virchows Arch. 2024. PMID: 39392508 Free PMC article.

95

ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity.

Agaimy A, Dermawan JK, Haller F, Semrau S, Meidenbauer N, Stoehr R, Lax S, Hartmann A, Zou YS, Xing D, Tögel L, Gross JM, Michal M. Agaimy A, et al. Virchows Arch. 2024 Nov;485(5):805-813. doi: 10.1007/s00428-024-03908-3. Epub 2024 Aug 28. Virchows Arch. 2024. PMID: 39196362 Free PMC article.

96

Fertility-sparing strategy in a rare case of highly malignant Dicer-1-associated sarcoma of the cervix.

Altmann J, Kubiak K, Sehouli J, Roser E. Altmann J, et al. Arch Gynecol Obstet. 2024 Nov;310(5):2617-2621. doi: 10.1007/s00404-024-07588-x. Epub 2024 Jul 8. Arch Gynecol Obstet. 2024. PMID: 38976022 Free PMC article.

97

Uterine cancer incidence trends and 5-year relative survival by race/ethnicity and histology among women under 50 years.

Wijayabahu AT, Shiels MS, Arend RC, Clarke MA. Wijayabahu AT, et al. Am J Obstet Gynecol. 2024 Nov;231(5):526.e1-526.e22. doi: 10.1016/j.ajog.2024.06.026. Epub 2024 Jun 24. Am J Obstet Gynecol. 2024. PMID: 38925206 Free PMC article.

98

Clinical characteristics and treatment outcomes of women with recurrent uterine leiomyosarcoma.

Yuan H, Wang Y, Li N, Wu L, Yao H. Yuan H, et al. Orphanet J Rare Dis. 2024 Oct 25;19(1):395. doi: 10.1186/s13023-024-03415-3. Orphanet J Rare Dis. 2024. PMID: 39456061 Free PMC article.

99

The utility of MRI for the preoperative differential diagnosis of uterine sarcoma and leiomyoma: a single-center study.

Yazawa H, Yazawa R, Anjo K, Inazuki A, Kikuta M. Yazawa H, et al. Fukushima J Med Sci. 2024 Oct 18;70(4):211-218. doi: 10.5387/fms.23-00018. Epub 2024 Oct 4. Fukushima J Med Sci. 2024. PMID: 39370272 Free PMC article.

100

ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas.

Ray-Coquard I, Casali PG, Croce S, Fennessy FM, Fischerova D, Jones R, Sanfilippo R, Zapardiel I, Amant F, Blay JY, Martἰn-Broto J, Casado A, Chiang S, Dei Tos AP, Haas R, Hensley ML, Hohenberger P, Kim JW, Kim SI, Meydanli MM, Pautier P, Abdul Razak AR, Sehouli J, van Houdt W, Planchamp F, Friedlander M. Ray-Coquard I, et al. Int J Gynecol Cancer. 2024 Oct 7;34(10):1499-1521. doi: 10.1136/ijgc-2024-005823. Int J Gynecol Cancer. 2024. PMID: 39322612 Free article. No abstract available.

101

Uterine carcinosarcomas: A case series of 9 cases from a low-income country.

Efared B, Koura HH, Bako ABA, Boubacar I, Boureima HS, Mahamadou G, Nouhou H. Efared B, et al. Medicine (Baltimore). 2024 Oct 4;103(40):e39773. doi: 10.1097/MD.0000000000039773. Medicine (Baltimore). 2024. PMID: 39465781 Free PMC article.

102

Coexistence of uterine adenosarcoma and endometrioid endometrial carcinoma: A case report and literature review.

Wang W, Li J, Xu J, Tang H, Chen Y, Guo D. Wang W, et al. Sci Prog. 2024 Oct-Dec;107(4):368504241296291. doi: 10.1177/00368504241296291. Sci Prog. 2024. PMID: 39523612 Free PMC article. Review.

103

Primary liposarcoma of the uterus with MDM2 negative.

Wei S, Zhang L, Han Y, Wang L. Wei S, et al. Indian J Pathol Microbiol. 2024 Oct 1;67(4):907-910. doi: 10.4103/ijpm.ijpm_263_23. Epub 2023 Nov 9. Indian J Pathol Microbiol. 2024. PMID: 38394412 Free article.

104

A Simple Eco-Friendly HPLC-PDA Method for the Simultaneous Determination of Paclitaxel and Seliciclib in Plasma Samples for Assessing Their Pharmacodynamics and Pharmacokinetics in Combination Therapy for Uterine Sarcoma.

Alsegiani AS, Alrubia S, Darwish IA. Alsegiani AS, et al. Medicina (Kaunas). 2024 Sep 29;60(10):1601. doi: 10.3390/medicina60101601. Medicina (Kaunas). 2024. PMID: 39459388 Free PMC article.

105

A rare case of aggressive uterine leiomyosarcoma: a case report.

Das S, Srivastava S, Srivastava P, Prasad N, Roy M, Sarkar I. Das S, et al. Pan Afr Med J. 2024 Sep 9;49:10. doi: 10.11604/pamj.2024.49.10.42105. eCollection 2024. Pan Afr Med J. 2024. PMID: 39372690 Free PMC article.

106

Clinicopathological and survival analysis for patients with uterine sarcoma treated following surgery for presumed benign disease.

Wang T, Yuan H, Li L, Yao H. Wang T, et al. BMC Cancer. 2024 Sep 9;24(1):1118. doi: 10.1186/s12885-024-12881-8. BMC Cancer. 2024. PMID: 39251969 Free PMC article.

107

Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma.

Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Le Cesne A, Balleyguier C, Archambaud B, Duffaud F; French Sarcoma Group. Pautier P, et al. N Engl J Med. 2024 Sep 5;391(9):789-799. doi: 10.1056/NEJMoa2403394. N Engl J Med. 2024. PMID: 39231341 Free article. Clinical Trial.

108

Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma.

Lee HHY, Chow KL, Wong HS, Chong TY, Wong AST, Cheng GHW, Ko JMK, Siu HC, Yeung MCF, Huen MSY, Tse KY, Bray MR, Mak TW, Leung SY, Ip PPC. Lee HHY, et al. Clin Cancer Res. 2024 Sep 3;30(17):3904-3918. doi: 10.1158/1078-0432.CCR-23-3720. Clin Cancer Res. 2024. PMID: 38848043 Free PMC article.

109

PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-Like Morphology.

Michal M, Agaimy A, Croce S, Mechtersheimer G, Gross JM, Xing D, Bell DA, Gupta S, Mosaieby E, Martínek P, Klubíčková N, Michalová K, Bouda J, Fínek J, Hernandez T, Michal M, Schoolmeester JK, Ondič O. Michal M, et al. Mod Pathol. 2024 Sep;37(9):100552. doi: 10.1016/j.modpat.2024.100552. Epub 2024 Jun 26. Mod Pathol. 2024. PMID: 38942115 Free article.

110

Letter to the Editor for the article 'Prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study'.

Fan W, Wang L, Xu Y, Chi H. Fan W, et al. Int J Surg. 2024 Sep 1;110(9):6016-6017. doi: 10.1097/JS9.0000000000001710. Int J Surg. 2024. PMID: 38814312 Free PMC article. No abstract available.

111

Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.

Huvila J, Jamieson A, Pors J, Hoang L, Mirkovic J, Cochrane D, McAlpine JN, Gilks CB. Huvila J, et al. Int J Gynecol Pathol. 2024 Sep 1;43(5):506-514. doi: 10.1097/PGP.0000000000001010. Epub 2024 Feb 2. Int J Gynecol Pathol. 2024. PMID: 38303106 Free PMC article.

112

Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma.

Yang Q, Falahati A, Khosh A, Lastra RR, Boyer TG, Al-Hendy A. Yang Q, et al. Cells. 2024 Aug 28;13(17):1443. doi: 10.3390/cells13171443. Cells. 2024. PMID: 39273015 Free PMC article.

113

The Potential of Immunotherapy for SMARCA4-Deficient Undifferentiated Uterine Sarcoma (SDUS).

Yao X, He Y, Xiao C, Zhou R, Zhao C, Wang W. Yao X, et al. Biomolecules. 2024 Aug 11;14(8):987. doi: 10.3390/biom14080987. Biomolecules. 2024. PMID: 39199375 Free PMC article.

114

A CARE-compliant article: A case report of retroperitoneal endometrial stromal sarcoma with multiple pulmonary metastases and literature review.

Fang Y, Zhou X, Bai J, Lin Q, Zheng Y, Bo S, Sui L, Zhu T, Bai N, Sun L. Fang Y, et al. Medicine (Baltimore). 2024 Aug 9;103(32):e39093. doi: 10.1097/MD.0000000000039093. Medicine (Baltimore). 2024. PMID: 39121276 Free PMC article. Review.

115

Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis.

Steinlechner M, Strobel L, Leitner K, Pan TL, Feroz B, Marth C, Zeimet AG. Steinlechner M, et al. Int J Gynecol Cancer. 2024 Aug 5;34(8):1196-1202. doi: 10.1136/ijgc-2023-005170. Int J Gynecol Cancer. 2024. PMID: 38688662 Free PMC article.

116

Ovarian Carcinoma: A Single-Centre Eight-Year Case-Series Study with Survival Analysis.

Subtirelu GD, Steriu A, Bratucu E. Subtirelu GD, et al. Chirurgia (Bucur). 2024 Aug;119(4):373-384. doi: 10.21614/chirurgia.3025. Chirurgia (Bucur). 2024. PMID: 39250607 Free article.

117

A rare adult case of primary uterine rhabdomyosarcoma with mixed pattern: a clinicopathological & immunohistochemical study with literature review.

Kamel NKH, Hasby EA. Kamel NKH, et al. Diagn Pathol. 2024 Jul 17;19(1):98. doi: 10.1186/s13000-024-01518-w. Diagn Pathol. 2024. PMID: 39020398 Free PMC article. Review.

118

Case report: Characterization of the immunologic and molecular landscape in a unique presentation of invasive lobular carcinoma with concurrent uterine carcinosarcoma treated with immunotherapy.

Riedinger CJ, Eisele CD, Esnakula A, Stover DG, Freud AG, Cosgrove CM. Riedinger CJ, et al. Front Immunol. 2024 Jul 15;15:1422342. doi: 10.3389/fimmu.2024.1422342. eCollection 2024. Front Immunol. 2024. PMID: 39076998 Free PMC article.

119

ATM, BLM, and CDH1 gene co-mutations in a high-grade endometrial stromal sarcoma patient with multiple abdominal cavity metastases: a case report and literature review.

Li N, Yan Y, Li Y, Yang Y, Dai C, Li N. Li N, et al. BMC Geriatr. 2024 Jul 15;24(1):603. doi: 10.1186/s12877-024-05201-z. BMC Geriatr. 2024. PMID: 39009979 Free PMC article. Review.

120

Unexpected rare uterine carcinosarcoma with neuroendocrine differentiation: Reflections on clinical diagnosis and treatment of a case report.

Shi Q, Wang L, Yao J. Shi Q, et al. Medicine (Baltimore). 2024 Jul 12;103(28):e38800. doi: 10.1097/MD.0000000000038800. Medicine (Baltimore). 2024. PMID: 38996113 Free PMC article.

121

Clinicopathological characteristics and prognosis of uterine sarcoma: a 10-year retrospective single-center study in China.

Wang JF, Li C, Yang JY, Wang YL, Ji J. Wang JF, et al. Diagn Pathol. 2024 Jul 5;19(1):94. doi: 10.1186/s13000-024-01517-x. Diagn Pathol. 2024. PMID: 38970112 Free PMC article.

122

Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.

Boscolo Bielo L, Repetto M, Crimini E, Belli C, Setola E, Parma G, Fusco N, Barberis M, Guerini Rocco E, Marra A, Colombo N, Curigliano G. Boscolo Bielo L, et al. Oncologist. 2024 Jul 5;29(7):560-565. doi: 10.1093/oncolo/oyae082. Oncologist. 2024. PMID: 38716772 Free PMC article.

123

COMPARISON OF CLINICOPATHOLOGICAL AND SURVIVAL ANALYSIS OF ENDOMETRIAL DEDIFFERENTIATED, UNDIFFERENTIATED CARCINOMAS AND CARCINOSARCOMAS.

Hassan U, Asrar I, Maqbool H, Hussain M, Hameed M, Loya A. Hassan U, et al. J Ayub Med Coll Abbottabad. 2024 Jul-Sep;36(3):596-605. doi: 10.55519/JAMC-03-13746. J Ayub Med Coll Abbottabad. 2024. PMID: 39623842 Free article.

124

Use of morcellation in laparoscopic myomectomy. Medical malpractice and medicolegal considerations.

Baldino G, Iannello D, Bartoloni G, Burrascano G, Asmundo A, Ventura Spagnolo E. Baldino G, et al. Clin Ter. 2024 Jul-Aug;175(Suppl 2(4)):130-133. doi: 10.7417/CT.2024.5100. Clin Ter. 2024. PMID: 39101410 Free article.

125

Myxoid leiomyosarcoma of the oviduct and uterus in a Cockatiel (Nymphicus hollandicus).

Golchin D, Borhanikiya A. Golchin D, et al. Vet Med Sci. 2024 Jul;10(4):e1520. doi: 10.1002/vms3.1520. Vet Med Sci. 2024. PMID: 38979745 Free PMC article.

126

2‑D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells.

Joung H, Liu H. Joung H, et al. Oncol Rep. 2024 Jul;52(1):97. doi: 10.3892/or.2024.8756. Epub 2024 Jun 14. Oncol Rep. 2024. PMID: 38874019 Free PMC article.

127

The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients.

Quan C, Zheng Z, Cao S, Wu Y, Zhang W, Huang Y. Quan C, et al. J Gynecol Oncol. 2024 Jul;35(4):e98. doi: 10.3802/jgo.2024.35.e98. Epub 2024 Apr 30. J Gynecol Oncol. 2024. PMID: 38725236 Free PMC article.

128

Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.

Al Khuri M, Al Salmi I, Al Ajmi H, Al Hadidi A, Alabousi A, Haider E, Vasudev P, Al Salmi A, Jose S, Alrahbi N. Al Khuri M, et al. Int J Gynecol Cancer. 2024 Jul 1;34(7):1027-1033. doi: 10.1136/ijgc-2023-005220. Int J Gynecol Cancer. 2024. PMID: 38658016 Free article.

129

SMARCA4 / BRG1 -deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4 -driven Gynecologic Malignancies.

Wei CH, Sadimin E, Agulnik M, Yost SE, Longacre TA, Fadare O. Wei CH, et al. Int J Gynecol Pathol. 2024 Jul 1;43(4):354-361. doi: 10.1097/PGP.0000000000000996. Epub 2023 Dec 12. Int J Gynecol Pathol. 2024. PMID: 38113031 Free PMC article.

130

Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.

Yang Q, Madueke-Laveaux OS, Cun H, Wlodarczyk M, Garcia N, Carvalho KC, Al-Hendy A. Yang Q, et al. Cells. 2024 Jun 26;13(13):1106. doi: 10.3390/cells13131106. Cells. 2024. PMID: 38994959 Free PMC article. Review.

131

Cytological diagnosis of patients with embryonal rhabdomyosarcoma of the cervix: case report and literature review.

Wei X, Li L. Wei X, et al. Diagn Pathol. 2024 Jun 3;19(1):73. doi: 10.1186/s13000-024-01497-y. Diagn Pathol. 2024. PMID: 38831464 Free PMC article. Review.

132

Recurrent low-grade uterine sarcoma: a diagnostic and therapeutic challenge.

Mateo-Kubach P, Ramirez PT, Pareja R, Deavers M, Farach AM. Mateo-Kubach P, et al. Int J Gynecol Cancer. 2024 Jun 3;34(6):946-950. doi: 10.1136/ijgc-2024-005428. Int J Gynecol Cancer. 2024. PMID: 38830668 Free article. No abstract available.

133

Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma?

Greco S, Pinheiro J, Cardoso-Carneiro D, Giantomassi F, Pellegrino P, Scaglione G, Delli Carpini G, Ciavattini A, Zannoni GF, Goteri G, Martinho O, Ciarmela P. Greco S, et al. Reprod Biomed Online. 2024 Jun;48(6):103816. doi: 10.1016/j.rbmo.2024.103816. Epub 2024 Jan 13. Reprod Biomed Online. 2024. PMID: 38608337 Free article.

134

E2F transcription factor-1 modulates expression of glutamine metabolic genes in mouse embryonic fibroblasts and uterine sarcoma cells.

Huber K, Giralt A, Dreos R, Michenthaler H, Geller S, Barquissau V, Ziegler DV, Tavernari D, Gallart-Ayala H, Krajina K, Jonas K, Ciriello G, Ivanisevic J, Prokesch A, Pichler M, Fajas L. Huber K, et al. Biochim Biophys Acta Mol Cell Res. 2024 Jun;1871(5):119721. doi: 10.1016/j.bbamcr.2024.119721. Epub 2024 Apr 3. Biochim Biophys Acta Mol Cell Res. 2024. PMID: 38580088 Free article.

135

Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis.

Raffone A, Raimondo D, Neola D, Travaglino A, Doglioli M, Ambrosio M, Raimondo I, De Meis L, Turco LC, Cosentino F, Seracchioli R, Casadio P, Mollo A. Raffone A, et al. Ultraschall Med. 2024 Jun;45(3):293-304. doi: 10.1055/a-2151-9205. Epub 2023 Aug 10. Ultraschall Med. 2024. PMID: 37562447 Free article. English.

136

Mullerian adenosarcoma of the uterus with MASO: a case report of cervical adenosarcoma in a young female that never had sexual behavior.

Chen JW, Huang YJ, Wang LL, Liu JJ, Shi MM, Li N. Chen JW, et al. BMC Womens Health. 2024 May 23;24(1):308. doi: 10.1186/s12905-024-03140-w. BMC Womens Health. 2024. PMID: 38783282 Free PMC article.

137

Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.

Xiao Y, Zhi Y, Cao G, Ma H, Gao J, Li F. Xiao Y, et al. J Cancer Res Clin Oncol. 2024 May 21;150(5):267. doi: 10.1007/s00432-024-05698-2. J Cancer Res Clin Oncol. 2024. PMID: 38769118 Free PMC article. Review.

138

Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.

Dermawan JK, Chiang S, Singer S, Jadeja B, Hensley ML, Tap WD, Movva S, Maki RG, Antonescu CR. Dermawan JK, et al. Clin Cancer Res. 2024 May 15;30(10):2260-2271. doi: 10.1158/1078-0432.CCR-24-0148. Clin Cancer Res. 2024. PMID: 38488807 Free PMC article.

139

Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.

Guo J, Zheng J, Tong J. Guo J, et al. Int J Med Sci. 2024 May 13;21(7):1227-1240. doi: 10.7150/ijms.93464. eCollection 2024. Int J Med Sci. 2024. PMID: 38818470 Free PMC article. Review.

140

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6^high uterine leiomyosarcoma to PD-1 blockade.

De Wispelaere W, Annibali D, Tuyaerts S, Messiaen J, Antoranz A, Shankar G, Dubroja N, Herreros-Pomares A, Baiden-Amissah REM, Orban MP, Delfini M, Berardi E, Van Brussel T, Schepers R, Philips G, Boeckx B, Baietti MF, Congedo L, HoWangYin KY, Bayon E, Van Rompuy AS, Leucci E, Tabruyn SP, Bosisio F, Mazzone M, Lambrechts D, Amant F. De Wispelaere W, et al. Clin Transl Med. 2024 May;14(5):e1655. doi: 10.1002/ctm2.1655. Clin Transl Med. 2024. PMID: 38711203 Free PMC article.

141

A case report of endometrial stromal sarcoma with sex-cord differentiation.

Wang H, Xie Y. Wang H, et al. Asian J Surg. 2024 May;47(5):2308-2309. doi: 10.1016/j.asjsur.2024.01.165. Epub 2024 Feb 7. Asian J Surg. 2024. PMID: 38331613 Free article. No abstract available.

142

The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma.

Toyohara Y, Sone K, Noda K, Yoshida K, Kato S, Kaiume M, Taguchi A, Kurokawa R, Osuga Y. Toyohara Y, et al. J Gynecol Oncol. 2024 May;35(3):e24. doi: 10.3802/jgo.2024.35.e24. Epub 2023 Dec 7. J Gynecol Oncol. 2024. PMID: 38246183 Free PMC article.

143

Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control study.

Abril J, Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Gulbech Ording A, Sørensen HT, Tretli S, Bjørge T. Abril J, et al. Cancer Causes Control. 2024 May;35(5):741-747. doi: 10.1007/s10552-023-01832-6. Epub 2023 Dec 22. Cancer Causes Control. 2024. PMID: 38129544 Free PMC article.

144

Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study.

De Bruyn C, Ceusters J, Vanden Brande K, Timmerman S, Froyman W, Timmerman D, Van Rompuy AS, Coosemans A, Van den Bosch T. De Bruyn C, et al. Ultrasound Obstet Gynecol. 2024 May;63(5):683-690. doi: 10.1002/uog.27535. Epub 2024 Apr 5. Ultrasound Obstet Gynecol. 2024. PMID: 37970762 Free article.

145

Refractory Pneumothorax Due to Cystic Pulmonary Metastasis of a Lowgrade Endometrial Stromal Sarcoma: A Case Report.

Watanabe H, Nakagawa T, Masuda R, Yamada S, Iwazaki M. Watanabe H, et al. Tokai J Exp Clin Med. 2024 Apr 20;49(1):31-34. Tokai J Exp Clin Med. 2024. PMID: 38509011 Free article.

146

Sarcoma of the uterine cervix: experience of a single center.

Yuan H, Li L, Li N, Yao H. Yuan H, et al. World J Surg Oncol. 2024 Apr 18;22(1):104. doi: 10.1186/s12957-024-03376-8. World J Surg Oncol. 2024. PMID: 38637834 Free PMC article.

147

FOXO3a deregulation in uterine smooth muscle tumors.

de Almeida TG, Ricci AR, Dos Anjos LG, Soares Junior JM, Maciel GAR, Baracat EC, Carvalho KC. de Almeida TG, et al. Clinics (Sao Paulo). 2024 Apr 17;79:100350. doi: 10.1016/j.clinsp.2024.100350. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 38636197 Free PMC article.

148

NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.

Türkmen O, Müftüoğlu KH, Dinçer N, Çelik ZE, Akar Inan S. Türkmen O, et al. Turk J Med Sci. 2024 Apr 16;54(4):804-810. doi: 10.55730/1300-0144.5852. eCollection 2024. Turk J Med Sci. 2024. PMID: 39295619 Free PMC article.

149

Prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study.

Dai Q, Xu B, Wu H, You Y, Li L. Dai Q, et al. Int J Surg. 2024 Apr 1;110(4):1919-1928. doi: 10.1097/JS9.0000000000001146. Int J Surg. 2024. PMID: 38329091 Free PMC article.

150

MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness.

Gonzalez-Molina J, Hahn P, Falcão RM, Gultekin O, Kokaraki G, Zanfagnin V, Braz Petta T, Lehti K, Carlson JW. Gonzalez-Molina J, et al. Mol Oncol. 2024 Apr;18(4):850-865. doi: 10.1002/1878-0261.13440. Epub 2023 Apr 28. Mol Oncol. 2024. PMID: 37078535 Free PMC article.

151

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).

Lumish M, Chui MH, Zhou Q, Iasonos A, Sarasohn D, Cohen S, Friedman C, Grisham R, Konner J, Kyi C, Rubinstein M, Troso-Sandoval T, Aghajanian C, Makker V. Lumish M, et al. Gynecol Oncol. 2024 Mar;182:75-81. doi: 10.1016/j.ygyno.2023.12.028. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262242 Free PMC article. Clinical Trial.

152

NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.

Szalai L, Vereczkey I, Szemes M, Rókusz A, Csernák E, Tóth E, Melegh Z. Szalai L, et al. Virchows Arch. 2024 Mar;484(3):527-531. doi: 10.1007/s00428-023-03724-1. Epub 2023 Dec 28. Virchows Arch. 2024. PMID: 38151535 Free PMC article.

153

Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.

Kitadai R, Nishikawa T, Yoshida H, Mizoguchi C, Yamamoto K, Kato T, Yonemori K. Kitadai R, et al. J Gynecol Oncol. 2024 Mar;35(2):e11. doi: 10.3802/jgo.2024.35.e11. Epub 2023 Oct 12. J Gynecol Oncol. 2024. PMID: 37914528 Free PMC article.

154

Endometrial Sarcoma Metastasis to the Pterygopalatine Fossa: A Case Report and Review of the Literature.

Austell PJ, Levinson JS, Plitt MA, Ghai R, Gattuso P, Rupcich CR, Tajudeen BA. Austell PJ, et al. Ear Nose Throat J. 2024 Mar;103(3):148-150. doi: 10.1177/0145561320983943. Epub 2021 Jan 8. Ear Nose Throat J. 2024. PMID: 33415993 Free article. Review.

155

Spinal intramedullary uterine carcinosarcoma metastasis.

Solis W, Youssef AM, Shaw R, Li Y. Solis W, et al. BMJ Case Rep. 2024 Feb 27;17(2):e259268. doi: 10.1136/bcr-2023-259268. BMJ Case Rep. 2024. PMID: 38417940 Free PMC article.

156

Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.

Chen X, Guo Q, Chen X, Zheng W, Kang Y, Cao D. Chen X, et al. BMC Med Imaging. 2024 Feb 19;24(1):48. doi: 10.1186/s12880-024-01225-4. BMC Med Imaging. 2024. PMID: 38373912 Free PMC article.

157

Nonpuerperal uterine inversion caused by an adenosarcoma: A case report.

Belghith C, Abdelmoula G, Garci M, Ghali Z, Armi S, Makni M, Dhieb F, Boumediene M, Jrad M, Mathlouthi N, Slimani O. Belghith C, et al. Tunis Med. 2024 Feb 5;102(2):116-118. doi: 10.62438/tunismed.v102i2.4352. Tunis Med. 2024. PMID: 38567479 Free PMC article. English.

158

Uterine smooth muscle tumors: a multicenter, retrospective, comparative study of clinical and ultrasound features.

Borella F, Mancarella M, Preti M, Mariani L, Stura I, Sciarrone A, Bertschy G, Leuzzi B, Piovano E, Valabrega G, Turinetto M, Pino I, Castellano I, Bertero L, Cassoni P, Cosma S, Franchi D, Benedetto C. Borella F, et al. Int J Gynecol Cancer. 2024 Feb 5;34(2):244-250. doi: 10.1136/ijgc-2023-004880. Int J Gynecol Cancer. 2024. PMID: 38054268 Free article.

159

Post-radiation uterine rhabdomyosarcoma.

Casanova C, Madeira JIM, Pereira da Silva N, Antunes C. Casanova C, et al. BMJ Case Rep. 2024 Jan 24;17(1):e258853. doi: 10.1136/bcr-2023-258853. BMJ Case Rep. 2024. PMID: 38272523 Free PMC article. No abstract available.

160

Successful clinical approach to the metastatic uterine leiomyosarcoma to the epicardium-a case report.

Krzelj K, Lekic A, Luksic VR, Milicic D, Ilic I, Simetic L, Dzepina ZS, Gasparovic H, Biocina B, Safradin I. Krzelj K, et al. BMC Cardiovasc Disord. 2024 Jan 13;24(1):49. doi: 10.1186/s12872-023-03689-8. BMC Cardiovasc Disord. 2024. PMID: 38218764 Free PMC article.

161

Correlation between malignant peritoneal cytology and survival in patients with uterine leiomyosarcoma and endometrial stromal sarcoma.

Du J, Hu D, Xing Y, He R, Cheng Y, Li H, Liu C, Liang X, Yang Y. Du J, et al. Int J Gynecol Cancer. 2024 Jan 5;34(1):58-65. doi: 10.1136/ijgc-2023-004792. Int J Gynecol Cancer. 2024. PMID: 37821125 Free article.

162

Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis.

Zhang R, Zhao W, Zhu X, Liu Y, Ding Q, Yang C, Zou H. Zhang R, et al. Sci Rep. 2024 Jan 2;14(1):37. doi: 10.1038/s41598-023-47668-7. Sci Rep. 2024. PMID: 38167455 Free PMC article.

163

Neutrophil to lymphocyte ratio as an assessment tool to differentiate between uterine sarcoma and myoma: a systematic review and meta-analysis.

Tabatabaei F, Babadi S, Nourigheimasi S, Ghaedi A, Khanzadeh M, Bazrgar A, Gargari MK, Khanzadeh S. Tabatabaei F, et al. BMC Cancer. 2024 Jan 2;24(1):12. doi: 10.1186/s12885-023-11775-5. BMC Cancer. 2024. PMID: 38166889 Free PMC article.

164

Risk assessment and prediction of occult uterine sarcoma in patients with presumed uterine fibroids before high-intensity focused ultrasound treatment.

Wang Q, Lin Z, Zhu X, Wang Y, Zhang Y, He M, Zhang L. Wang Q, et al. Int J Hyperthermia. 2024;41(1):2385600. doi: 10.1080/02656736.2024.2385600. Epub 2024 Jul 31. Int J Hyperthermia. 2024. PMID: 39084650 Free article.

165

Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature.

Verma A, Tomar R, Chaturvedi A, Dhankar N, Mallya V, Khurana N. Verma A, et al. J Cancer Res Ther. 2024 Jan 1;20(1):150-155. doi: 10.4103/jcrt.jcrt_741_22. Epub 2023 Apr 7. J Cancer Res Ther. 2024. PMID: 38554313 Free article. Review.

166

Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper.

Laganà AS, Romano A, Vanhie A, Bafort C, Götte M, Aaltonen LA, Mas A, De Bruyn C, Van den Bosch T, Coosemans A, Guerriero S, Haimovich S, Tanos V, Bongers M, Barra F, Al-Hendy A, Chiantera V, Leone Roberti Maggiore U. Laganà AS, et al. Gynecol Obstet Invest. 2024;89(2):73-86. doi: 10.1159/000537730. Epub 2024 Feb 21. Gynecol Obstet Invest. 2024. PMID: 38382486 Free article. Review.

167

Uterine haemangiosarcoma in a Netherland Dwarf rabbit (Oryctolagus cuniculus Netherland dwarf).

Murakami M, Yonemaru K, Hirata A, Sakai H. Murakami M, et al. Vet Med Sci. 2024 Jan;10(1):e1311. doi: 10.1002/vms3.1311. Epub 2023 Nov 21. Vet Med Sci. 2024. PMID: 37990488 Free PMC article.

168

FTIR Microspectroscopy as a new probe to study human uterine lesions: Characterization of tumor cell lines from uterine smooth muscle cells and evaluation of EPA and DHA in vitro treatments.

Belloni A, Notarstefano V, Greco S, Pellegrino P, Giorgini E, Ciarmela P. Belloni A, et al. Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166873. doi: 10.1016/j.bbadis.2023.166873. Epub 2023 Sep 2. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 37666437 Free article.

169

A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.

Ise K, Tanei ZI, Oda Y, Tanikawa S, Sugino H, Ishida Y, Tsuda M, Gotoda Y, Nishiwaki K, Yanai H, Hasegawa T, Nagashima K, Tanaka S. Ise K, et al. Int J Gynecol Pathol. 2024 Jan 1;43(1):41-46. doi: 10.1097/PGP.0000000000000949. Epub 2023 Jun 14. Int J Gynecol Pathol. 2024. PMID: 37406360 Free article.

170

Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.

Xing D, Meyer CF, Gross JM, Argani P, Hung CF, Wu TC, Vang R, Armstrong DK, Gaillard SL. Xing D, et al. Int J Gynecol Pathol. 2024 Jan 1;43(1):47-55. doi: 10.1097/PGP.0000000000000951. Epub 2023 Mar 13. Int J Gynecol Pathol. 2024. PMID: 37043646 Free PMC article. Review.

171

Uterine carcinosarcoma showing immature teratoid-like differentiation.

Naito M, Terasaki M, Ouchi N, Toyoshima M. Naito M, et al. BMJ Case Rep. 2023 Dec 28;16(12):e257228. doi: 10.1136/bcr-2023-257228. BMJ Case Rep. 2023. PMID: 38154864 Free PMC article.

172

Embryonal rhabdomyosarcoma of the uterine cervix.

Qin Q, Yu Z, Tang Y. Qin Q, et al. Med Ultrason. 2023 Dec 27;25(4):475-476. doi: 10.11152/mu-4309. Med Ultrason. 2023. PMID: 38150685 Free article.

173

Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.

Garcia N, Ulin M, Yang Q, Ali M, Bosland MC, Zeng W, Chen L, Al-Hendy A. Garcia N, et al. Cells. 2023 Dec 13;12(24):2830. doi: 10.3390/cells12242830. Cells. 2023. PMID: 38132150 Free PMC article.

174

Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.

Makk E, Bohonyi N, Oszter A, Éles K, Tornóczky T, Tóth A, Kálmán E, Kovács K. Makk E, et al. Pathol Oncol Res. 2023 Dec 11;29:1611547. doi: 10.3389/pore.2023.1611547. eCollection 2023. Pathol Oncol Res. 2023. PMID: 38146588 Free PMC article.

175

A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.

Kim K, Kim S, Ahn T, Kim H, Shin SJ, Choi CH, Park S, Kim YB, No JH, Suh DH. Kim K, et al. BMC Cancer. 2023 Dec 8;23(1):1215. doi: 10.1186/s12885-023-11394-0. BMC Cancer. 2023. PMID: 38066476 Free PMC article.

176

Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.

Kotowicz B, Dańska-Bidzińska A, Fuksiewicz M, Nasierowska-Guttmejer A, Raczkiewicz D, Gujski M, Piątek S, Bidziński M. Kotowicz B, et al. Med Sci Monit. 2023 Dec 7;29:e941562. doi: 10.12659/MSM.941562. Med Sci Monit. 2023. PMID: 38058118 Free PMC article.

177

Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.

Hwang JR, Cho YJ, Ryu JY, Choi JY, Choi JJ, Sa JK, Kim HS, Lee JW. Hwang JR, et al. Biomed Pharmacother. 2023 Dec;168:115792. doi: 10.1016/j.biopha.2023.115792. Epub 2023 Nov 3. Biomed Pharmacother. 2023. PMID: 37924789 Free article.

178

Radical surgery of a recurrent low grade endometrial stromal sarcoma with a comprehensive intravenous growth from ovarian vein to the right ventricle - a case report.

Vujić G, Korda ZA, Kosi Bijelić N, Škopljanac Mačina A, Juranko V, Alfirević I, Mikuš M. Vujić G, et al. J Obstet Gynaecol. 2023 Dec;43(1):2186777. doi: 10.1080/01443615.2023.2186777. J Obstet Gynaecol. 2023. PMID: 36920179 Free article. No abstract available.

179

HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report.

Zheng F, Tian X. Zheng F, et al. J Obstet Gynaecol. 2023 Dec;43(1):2125301. doi: 10.1080/01443615.2022.2125301. Epub 2022 Sep 23. J Obstet Gynaecol. 2023. PMID: 36149352 Free article. No abstract available.

180

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

Navaridas R, Vidal-Sabanés M, Ruiz-Mitjana A, Altés G, Perramon-Güell A, Yeramian A, Egea J, Encinas M, Gatius S, Matias-Guiu X, Dolcet X. Navaridas R, et al. Adv Sci (Weinh). 2023 Nov;10(32):e2303134. doi: 10.1002/advs.202303134. Epub 2023 Sep 25. Adv Sci (Weinh). 2023. PMID: 37749866 Free PMC article.

181

Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and CTNNB1 Translocation : A Report of 3 Cases.

Boyraz B, da Cruz Paula A, Deveraux KA, Tran I, da Silva EM, Young RH, Snuderl M, Weigelt B, Oliva E. Boyraz B, et al. Am J Surg Pathol. 2023 Nov 1;47(11):1285-1290. doi: 10.1097/PAS.0000000000002094. Epub 2023 Aug 15. Am J Surg Pathol. 2023. PMID: 37584555 Free PMC article.

182

A case report with discussion on the treatment of vaginal endometrial stromal sarcoma.

Fu KY, Pei KG, Yin RT. Fu KY, et al. Asian J Surg. 2023 Nov;46(11):5190-5191. doi: 10.1016/j.asjsur.2023.07.015. Epub 2023 Aug 3. Asian J Surg. 2023. PMID: 37541888 Free article. No abstract available.

183

Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis.

Kim Y, Kang GH, Kim H. Kim Y, et al. J Gynecol Oncol. 2023 Nov;34(6):e73. doi: 10.3802/jgo.2023.34.e73. Epub 2023 Jun 26. J Gynecol Oncol. 2023. PMID: 37417301 Free PMC article.

184

High-fat diet promotes tumor growth in the patient-derived orthotopic xenograft (PDOX) mouse model of ER positive endometrial cancer.

Shen K, Shen D, Jin D, Zheng Y, Zhu Y, Zhao X, Zhang Z, Wang N, Chen H, Yang L. Shen K, et al. Sci Rep. 2023 Oct 2;13(1):16537. doi: 10.1038/s41598-023-43797-1. Sci Rep. 2023. PMID: 37783734 Free PMC article.

185

Scalp recurrence of uterine leiomyosarcoma.

Veiga N, Muruzábal JC. Veiga N, et al. Int J Gynecol Cancer. 2023 Oct 2;33(10):1666. doi: 10.1136/ijgc-2023-004522. Int J Gynecol Cancer. 2023. PMID: 37666528 Free article. No abstract available.

186

High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.

Wagh V, Menon S, Maheshwari A, Gupta S, Deodhar KK, Rekhi B. Wagh V, et al. Indian J Pathol Microbiol. 2023 Oct-Dec;66(4):829-833. doi: 10.4103/ijpm.ijpm_1021_22. Indian J Pathol Microbiol. 2023. PMID: 38084541 Free article.

187

The uterine adenosarcoma with postoperative residual in a woman treated by total abdominal hysterectomy/bilateral salpingo-oophorectomy: A case report and review of literature.

Fadavi P, Garousi M, Soltani S, Montazer F, Abolhasani M, Asgari S, Mirzaee E. Fadavi P, et al. Cancer Rep (Hoboken). 2023 Oct;6(10):e1891. doi: 10.1002/cnr2.1891. Epub 2023 Aug 17. Cancer Rep (Hoboken). 2023. PMID: 37592402 Free PMC article. Review.

188

The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features.

Trecourt A, Azmani R, Hostein I, Blanchard L, Le Loarer F, Bourdon A, Alame M, Nadaud B, Mayer L, Rebier F, Larmonier C, Moura MS, Soubeyran I, Hartog C, Ray-Coquard I, Treilleux I, Devouassoux-Shisheboran M, Croce S. Trecourt A, et al. Mod Pathol. 2023 Oct;36(10):100243. doi: 10.1016/j.modpat.2023.100243. Epub 2023 Jun 10. Mod Pathol. 2023. PMID: 37307879 Free article.

189

A rare case of primary isolated myeloid sarcoma arising at the uterine cervix.

Hu J, Xiao Y, Liu Y, Zhang D. Hu J, et al. Asian J Surg. 2023 Oct;46(10):4533-4535. doi: 10.1016/j.asjsur.2023.04.142. Epub 2023 May 10. Asian J Surg. 2023. PMID: 37173241 Free article. No abstract available.

190

Survival of patients living with HIV and cancer in Cali, Colombia.

Parra-Lara LG, Arango-Ibañez JP, Martínez-Arboleda JJ, Bravo JC, Zambrano ÁR, Collazos P, Andino F, Badillo A, Estrada S, Rosso F. Parra-Lara LG, et al. Colomb Med (Cali). 2023 Sep 30;54(3):e2015558. doi: 10.25100/cm.v54i3.5588. eCollection 2023 Jul-Sep. Colomb Med (Cali). 2023. PMID: 38098512 Free PMC article.

191

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).

Ingham M, Allred JB, Chen L, Das B, Kochupurakkal B, Gano K, George S, Attia S, Burgess MA, Seetharam M, Boikos SA, Bui N, Chen JL, Close JL, Cote GM, Thaker PH, Ivy SP, Bose S, D'Andrea A, Marino-Enriquez A, Shapiro GI, Schwartz GK. Ingham M, et al. J Clin Oncol. 2023 Sep 1;41(25):4154-4163. doi: 10.1200/JCO.23.00402. Epub 2023 Jul 19. J Clin Oncol. 2023. PMID: 37467452 Free PMC article.

192

Uterine sarcoma: almost more tumor than patient.

Ellis LB, Jones B, Yagel I, Walker-Jacobs A, Galani A, Hamlyn L, Kyrgiou M. Ellis LB, et al. Arch Gynecol Obstet. 2023 Sep;308(3):1035-1036. doi: 10.1007/s00404-023-07102-9. Epub 2023 Jun 15. Arch Gynecol Obstet. 2023. PMID: 37318612 Free PMC article. No abstract available.

193

An unusual case of hepatic metastasis from uterine leiomyosarcomas.

Cui M, Xiao P, Wei C, Wang J. Cui M, et al. Asian J Surg. 2023 Sep;46(9):3892-3893. doi: 10.1016/j.asjsur.2023.03.157. Epub 2023 Apr 8. Asian J Surg. 2023. PMID: 37037742 Free article. No abstract available.

194

Myxoid leiomyosarcoma of the uterine cervix: A case report.

Wu Y, Ying H, Wang J. Wu Y, et al. Asian J Surg. 2023 Sep;46(9):3835-3836. doi: 10.1016/j.asjsur.2023.03.128. Epub 2023 Apr 3. Asian J Surg. 2023. PMID: 37019779 Free article. No abstract available.

195

Uterine epithelioid smooth muscle tumor of uncertain malignant potential.

Gomez NF, Zhao J, Smith B. Gomez NF, et al. Int J Gynecol Cancer. 2023 Aug 7;33(8):1324-1325. doi: 10.1136/ijgc-2022-004117. Int J Gynecol Cancer. 2023. PMID: 37268311 Free article. No abstract available.

196

Uterine alveolar soft part sarcoma - an unexpected case.

Gama JM, Quick CM. Gama JM, et al. Int J Gynecol Cancer. 2023 Aug 7;33(8):1322-1323. doi: 10.1136/ijgc-2022-004173. Int J Gynecol Cancer. 2023. PMID: 37146992 Free article. No abstract available.

197

Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.

Kumagai K, Yagi T, Yamazaki M, Tasaki A, Asatani M, Ishikawa H. Kumagai K, et al. Medicine (Baltimore). 2023 Aug 4;102(31):e34452. doi: 10.1097/MD.0000000000034452. Medicine (Baltimore). 2023. PMID: 37543807 Free PMC article.

198

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy.

Psilopatis I, Damaskos C, Garmpis N, Vrettou K, Garmpi A, Sarantis P, Koustas E, Antoniou EA, Kouraklis G, Chionis A, Kontzoglou K, Dimitroulis D. Psilopatis I, et al. Int J Mol Sci. 2023 Aug 2;24(15):12353. doi: 10.3390/ijms241512353. Int J Mol Sci. 2023. PMID: 37569726 Free PMC article. Review.

199

Uterine sarcomas: A critical review of the literature.

Giannini A, Golia D'Augè T, Bogani G, Laganà AS, Chiantera V, Vizza E, Muzii L, Di Donato V. Giannini A, et al. Eur J Obstet Gynecol Reprod Biol. 2023 Aug;287:166-170. doi: 10.1016/j.ejogrb.2023.06.016. Epub 2023 Jun 17. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 37348383 Free article. Review.

200

Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.

Kobayashi Y, Yokoi A, Hashimura M, Oguri Y, Konno R, Matsumoto T, Tochimoto M, Nakagawa M, Ishibashi Y, Ito T, Ohhigata K, Harada Y, Fukagawa N, Kodera Y, Saegusa M. Kobayashi Y, et al. Am J Pathol. 2023 Aug;193(8):1116-1128. doi: 10.1016/j.ajpath.2023.04.011. Epub 2023 May 9. Am J Pathol. 2023. PMID: 37169340 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,546 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,546 results

Results by year